CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma

作者：Yanan Gao, Xing Fan, Nan Li, Chengzhi Du, Bin Yang, Wenhao Qin, Jing Fu, Geoffrey J. Markowitz, Hongyang Wang, Jianli Ma, Shuqun Cheng, Pengyuan Yang · 发表于：Pharmacological Research · 年份：2020 · DOI：10.1016/j.phrs.2020.104800 · 被引用次数：32 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Hepatitis B Virus Studies、Liver physiology and pathology